reports

Zacks Small Cap Research – CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Update on the DrugSorb-ATR Regulatory Process Management reiterated that their De Novo DrugSorb-ATR submission continued to be in interactive review with FDA, that their Medical Device License application to Health Canada was in advanced review, and that they continue to expect regulatory decisions in … Read more

Fluffy on the Facts and the Future – A Reflection on Competitiveness, Competition and Sustainability in the Letta and Draghi Reports and the EU’s responses – Go Health Pro

by
Fluffy on the Facts and the Future – A Reflection on Competitiveness, Competition and Sustainability in the Letta and Draghi Reports and the EU’s responses – Go Health Pro

Introduction The last year has seen the publication of the Letta and Draghi Reports and a flurry of EU Deals all concerning the EU’s competitiveness. The recurring theme is the imminent demise of Europe. This pessimism is fed by industrial decline, the election of Donald Trump and the impact of that on the liberal world … Read more

Zacks Small Cap Research – SDOT: Sadot Group Reports 2024 Financial Results Which Showed the First Full Year Positive Net Income in the Company’s History – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDOT READ THE FULL SDOT RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results On March 11, 2025, Sadot Group (NASDAQ:SDOT) reported 4th quarter and full year 2024 results which showed continued strength in the commodity trading business. In the latest filings, the restaurant operations have been reported as discontinued … Read more

Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

by
Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th quarter and full year 2024 financial results on March 12th which were largely in line with our expectations. Research and development expenses for 2024 were $8.8 million compared to $10.6 million in … Read more

iA Financial reports record core earnings in 2024, plans growth strategy update – Go Health Pro

by
iA Financial reports record core earnings in 2024, plans growth strategy update – Go Health Pro

iA Financial Group reported core earnings of $3.04 per diluted share in the fourth quarter of 2024, a 30% increase from a year ago.   For the full year, core earnings exceeded $1 billion, reaching $1.07 billion. Core EPS was $11.16, reflecting a 20% increase from 2023.  Denis Ricard (pictured), president and chief executive officer of … Read more